Pregnancy

Reunion to Sponsor Scholarships that will Train Healthcare Professionals on Maternal Mental Health Disorders, including Postpartum Depression Reunion’s Phase 2 RECONNECT Study in Postpartum Depression is Actively Recruiting Patients MORRISTOWN, N.J., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserved mental health disorders through the advancement of next-generation psychedelic therapeutic solutions, today announced a new partnership with the Seleni Institute, a New York City based nonprofit that provides treatment and training regarding maternal mental health and wellness issues. This partnership will grant healthcare professionals access to the Seleni Institute’s comprehensive, evidence-based training on maternal mental health conditions such as perinatal mood and anxiety disorders (PMADs) and perinatal grief. The courses provide expert instruction on the effective diagnosis and treatment of reproductive and maternal health disorders including postpartum depression (PPD). “At Reunion, we recognize the urgent need to address and increase awareness of maternal mental health conditions, which affect 1 in 5 women during pregnancy or following childbirth. Through our partnership with the Seleni Institute and sponsorship of evidence-based training courses, we aim to ensure that healthcare professionals have access to valuable educational resources to more effectively diagnose and treat maternal mental health disorders,” said Greg Mayes, President and Chief Executive Officer of Reunion Neuroscience. “In tandem with this partnership, we continue to support the broader maternal mental health community with the advancement of our Phase 2 RECONNECT trial evaluating our lead candidate RE104 in adult female patients with moderate-to-severe PPD.” The RECONNECT Phase 2 clinical trial (NCT06342310), a multicenter, randomized, double-blind, active dose-controlled clinical trial is evaluating the safety and efficacy of a single subcutaneous dose of RE104 in adult female patients with moderate-to-severe PPD. To learn more about the study and eligibility for enrollment, please visit www.ppdreconnectstudy.com. “We are thrilled to partner with Reunion Neuroscience in our shared mission to support maternal mental health,” said Seema Bajaj, Executive Director of the Seleni Institute. “Through this sponsorship, Reunion is collaborating in our initiative to provide access to valuable training materials to better equip healthcare providers with the knowledge and tools necessary to properly address these critical issues, including PPD. We are proud to continue our combined efforts to further increase awareness and reduce stigma around reproductive and maternal mental health conditions.” Since its inception in 2011, the Seleni Institute has been at the forefront of advancing maternal mental health, having trained over 6,200 professionals across 30 countries and impacted more than 10 million lives globally. Seleni offers a hybrid approach that includes clinical services for individuals, couples, and families as well as accredited training for healthcare providers. About Reunion Neuroscience Inc.Reunion Neuroscience is a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserved mental health disorders through the advancement of next-generation psychedelic therapeutic solutions. In August of 2023, Reunion Neuroscience became a private company and in May 2024, the Company completed a Series A financing co-led by MPM BioImpact and Novo Holdings. Reunion is actively investigating the use of its lead product candidate, RE104, in postpartum depression, as well as in additional neuropsychiatric indications, including adjustment disorders in patients diagnosed with mental illnesses like cancer, where there remains a significant unmet need that is not addressed by the current standard of care. For more information about the company, visit https://reunionneuro.com. About the Seleni InstituteThe Seleni Institute is a leading therapy center and global training organization committed to advancing women’s mental health through all stages of reproductive life. As a recognized leader in maternal and reproductive mental health, Seleni provides specialized therapy services for individuals, couples, and families navigating challenges such as infertility, pregnancy, and menopause, while equipping health professionals with the tools to diagnose and treat reproductive mental health issues effectively. Founded in 2011 by George and Nitzia Logothetis, Seleni has positively impacted over 10 million lives worldwide. Learn about how Seleni supports mental health for life’s milestones at seleni.org and explore the organization’s training curriculum at training.seleni.org. For more information on the Seleni Scholarship and to apply, please visit Seleni Scholarship for Maternal Mental Health Professionals. For further information: IR Inquiries:Courtney MogerleyPrecision AQcourtney.mogerley@precisionaq.com PR Inquiries:Ashley Murphy Precision AQashley.murphy@precisionaq.com

PatientPoint, a patient engagement company, announced a partnership with MyHealthTeam, a social network company. The partnership aims to provide patients in more than 35,000 PatientPoint locations the chance to connect with and get support from other people who have the same chronic health problems. PatientPoint's waiting room and exam room screens feature messages that touts MyHealthTeam's platform which serves patients via a growing network of greater than 60 patient communities. When patients scan a QR code on PatientPoint's devices, they become part of pertinent online communities where they can get support from other patients, as well as information to help guide them in managing their healthcare. According to the two companies in a five-week pilot program, the partnership witnessed a strong commitment among patients with obesity or diabetes. "Our partnership with MyHealthTeam underscores PatientPoint's dedication to delivering relevant resources and information in the critical moments when care decisions are made," Mike Collette, founder and chief executive officer at PatientPoint, said in a statement. "This collaboration reinforces our leadership in the point-of-care space and furthers our purpose of empowering better health for all. We know educated, engaged, empowered patients make better decisions about their health, leading to patients living more supported, informed and fulfilled lives as they manage their conditions." Eric Peacock, cofounder and chief executive officer of MyHealthTeam noted that with the partnership, patients will be able to get the care they need from their doctor, plus ongoing support, guidance and education they need when they are not with their doctor. "By making MyHealthTeam's patient communities available through PatientPoint's extensive network of physician offices, we can improve health outcomes by providing timely support and information helping people feel more connected and informed before, during and after their visit with the doctor," said Peacock. THE LARGER TREND In 2021, PatientPoint merged with Outcome Health creating a new platform, PatientPoint Health Technologies, aimed at facilitating patient-clinician communications. In 2019, PatientPoint joined forces with the American Medical Association (AMA), to help in the management of Type 2 diabetes and cardiovascular disease. The tech companies teamed up to disseminate AMA-developed chronic disease education and engagement content via its point of care digital platform. In 2022, MyHealthTeam created a network for people with long COVID. The myCOVIDteam tool was the result of a partnership between MyHealthTeam and South African payer Discovery. The new community is designed to offer individuals living with long COVID foundational information, including risk facts, symptoms and treatment options. In 2020, MyHealthTeam teamed up with EMD Serono for a new information resource for patients with multiple sclerosis (MS) who are pregnant or might become pregnant. The tool, Family Planning Resource Center, is available within MyMS team, part of MyHealthTeam’s social network, designed to help individuals experiencing MS connect to each other. Patients use the feature to read about common myths linked with MS and pregnancy.

METUCHEN, N.J., Aug. 8, 2024 /PRNewswire/ -- Dentistry.One, a virtual-first dental care solution introduced by MouthWatch, LLC, has been selected by Health Plan of San Mateo (HPSM), San Mateo County's largest non-profit Medicare/Medicaid public health plan, to provide virtual dental care for its nearly 150,000 Medi-Cal and dual eligible members. This benefit will be a valuable complement to HPSM Dental, California's first and only dental plan for Medi-Cal members that is fully integrated with medical and mental health care benefits. Under the new agreement, HPSM members will have access to Dentistry.One's virtual dental care network of experienced, highly trained dentists and Care Advisors. These experts in dental hygiene provide personalized oral health care advice and patient care coordination. Available anytime, from anywhere, Dentistry.One addresses a broad range of dental issues, including: Emergency tooth pain. Starting the journey to healthier teeth and gums. Understanding available dental benefits. Arranging in-person appointments with local providers in the HPSM Dental network. Selecting the best products for specific dental needs. Answering questions about treatment options. HPSM members will enjoy the simplicity and convenience of selecting a Dentistry.One appointment that works best for their schedule. Appointments can include live video consultations and uploading photos so a dentist can diagnose the member's condition. Dentistry.One then sends a personalized Oral Health Report with recommended next steps to the member within 24 hours of a visit. With nearly 2% of emergency department (ED) visits being dental-related, Dentistry.One also provides a less time-consuming, more cost-effective alternative to expensive ED trips. Furthermore, nearly 70 million Americans live in areas with a shortage of dental health professionals. San Mateo County is one of these "dental deserts," according to the U.S. Department of Health and Human Services. "Dentistry.One shares Health Plan of San Mateo's deep commitment to help residents of San Mateo County with limited income and resources live their healthiest lives," said Brant Herman, Founder & Chief Executive Officer of MouthWatch and Dentistry.One. "We look forward to offering HPSM members an innovative virtual dental care benefit that eliminates barriers to care, increases utilization, and drives better health outcomes. Virtual services are especially important for those with chronic conditions such as diabetes, heart disease, cancer, or pregnancy where better dental care has proven to improve overall health." Studies show that people living with certain chronic conditions more often have untreated oral diseases or conditions. For example, according to the Centers for Disease Control & Prevention (CDC), gum disease can worsen glycemic control (blood sugar level) in people living with diabetes. "Partnering with Dentistry.One exemplifies our 35-year commitment to the vision that Healthy is for everyone, which extends beyond solely addressing medical needs by integrating dental care," said Carolyn Brown, DDS, Health Plan of San Mateo Dental Director. "Offering our members access to Dentistry.One virtual dental services underscores our recognition that oral health is vital to overall well-being. The service will provide a tangible solution for increasing access to the oral health care our members need and deserve." HPSM members can start using Dentistry.One online through a co-branded Dentistry.One and HPSM webpage. Dentistry.One's national network of dentists and Care Advisors is available to individuals, health plans, and other organizations focused on patient health. If you are an organization and want to learn more about how to seamlessly integrate Dentistry.One into an existing benefits portfolio or add it as an affordable stand-alone option, visit dentistry.one to schedule an introduction. About Health Plan of San Mateo (HPSM) HPSM is a local, non-profit County Organized Health System (COHS) founded in 1987. HPSM's mission is to ensure that San Mateo County's residents with limited income and resources have access to high-quality care, services, and support so they can live the healthiest lives possible. With more than 150,000 members or participants, HPSM serves all of the County's Medi-Cal eligible residents, nearly 9,000 members eligible for both Medicare and Medi-Cal, as well as families, seniors, people with disabilities, and children with complex medical conditions. HPSM also sponsors special programs that address the complex social issues that some eligible members face from home-based health care to affordable housing for the homeless. Learn more at . About MouthWatch, LLC MouthWatch, LLC, is a leader in developing digital technology solutions that drive success for dental professionals, improve oral health care, and enhance the overall patient experience. Headquartered in Metuchen, New Jersey, MouthWatch is widely known for its intraoral cameras that help engage patients in treatment planning through high-quality, affordable imaging technology, and its TeleDent software that provides practices and organizations with a teledentistry option to engage patients with providers remotely. MouthWatch recently launched Dentistry.One, a virtual-first care network that addresses the expectations of today's modern healthcare consumers, the need for greater efficiency in healthcare, and the proven connection between good oral health and total health. Dentistry.One features on-demand dental consultations, personalized care coordination, and oral health coaching for prioritizing oral health. MouthWatch hardware and software is in use at over 40,000 practices, over 30 leading Dental Service Organizations (DSOs), and over 100 dental schools. The company has been recognized three times in the Inc. 5000. For more information, visit mouthwatch.com or dentistry.one. Media Contact: Michael Ventriello 732-939-3943 [email protected] SOURCE Dentistry.One